In summary, our results showed that RBM5 significantly inhibits tumor growth and induces apoptosis of lung cancer cells by reducing the expression of Bcl-2, subsequently inducing the expression of cleaved caspase-3, cleaved caspase-9 and cleaved PARP. Here, CASP3 is linked to lung carcinoma.